ADMS gets FDA approval as expected, stock goes up
Post# of 72433
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
This was expected, as they released their good Phase III results a year ago, so the stock had already priced quite a bit of the positive news into it already.
And, this is not a NEW drug, it's just a time-release formulation of an old drug.
What do you think would happen if, for instance, a small biotech released great data on a NEW type of drug? Hmmm?
![](/images/icons/icon_biggrin.gif)
Lots more than 50% up, that's my guess.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)